Inadequate vitamin B-6 status is common among elderly people. It is still unclear to what extent factors other than reduced vitamin B-6 intake are responsible for this. We studied the vitamin B-6 intake and status [measured as plasma pyridoxal 5'-phosphate (PLP)] in 546 elderly Europeans, aged 74-76 years, with no known vitamin B-6 supplement use. In addition, we examined interrelations and associations with other dietary and lifestyle factors, including indicators of physical health. Overall, 27% of the males and 42% of the females had dietary vitamin B-6 intakes below the mean minimum requirements (.015 mg/g protein and/or < 1.0 mg/day), and 22% of both males and females had low plasma PLP levels (< 20 nmol/L). Plasma PLP was positively associated with vitamin B-6 intake, alcohol intake, and serum albumin, and was weakly negatively associated with body mass index. Although the serum albumin levels fell within the normal range, these findings suggest that this transport protein is related with vitamin B-6 status of elderly people, either directly or as a result of underlying health problems. It is concluded that, based on the references for younger adults, the vitamin B-6 status of elderly people is marginal. Trials are needed to quantify functional and health consequences of improving the vitamin B-6 status of elderly people.
T HE aging process is associated with health deterioration, resulting in reduced food intakes that may lead to nutrient deficiencies (Shock, 1984; Munro, 1989; van der Wielen et al., 1996) . Since the population of elderly people is rapidly increasing, much attention is being paid to identify vulnerable categories of elderly people who are at risk of subclinical deficiencies for several nutrients.
A marginal intake of vitamin B-6 has been found in several studies on elderly people (Russell and Suter, 1993; van der Wielen et al., 1994) . Plasma pyridoxal 5'-phosphate (PLP), which is a circulating form of vitamin B-6 and reflects recent intake, is also often lower in elderly people when compared to younger adults (Rose et al., 1976; Guilland et al., 1984; Lee and Leklem, 1985; Schrijver et al., 1985; Tolonen et al., 1987; Lowik et al., 1989; Manore et al., 1989; Haller et al., 1991; Pannemans et al., 1994) . It is not clear to what extent a lower dietary vitamin B-6 intake is responsible for this age-related reduction in PLP levels. Several factors have been found to affect vitamin B-6 bioavailability. For instance, vitamin B-6 bioavailability from animal sources is greater than from vegetable origin (Leklemet al., 1980; Kretschetal., 1982; Kabiretal., 1983; Fisher et al., 1984) . This may be due to the presence of pyridoxine glycosides in the latter sources (Reynolds, 1988) .
Vitamin B-6 plays an important role in protein metabolism. PLP is an essential cofactor in the formation of cystathionine from homocysteine (Rees and Rodgers, 1993) . Homocysteine is assumed to be capable of damaging the arterial intima, which may lead to atherosclerosis (McCully and Wilson, 1975) . The influence of protein intake on vitamin B-6 metabolism in elderly people is not clear. In younger adults a negative association between protein intake and vitamin B-6 status has been reported (Miller et al., 1985; Pannemans et al., 1994) , whereas this association is less pronounced in elderly subjects (Pannemans et al., 1994) . Experimental studies have suggested increased PLP degradation and reduced PLP formation in alcoholics (Lumeng and Li, 1974; Labadarios et al., 1977) . Recently, Lowik et al. (1994) suggested an interaction between riboflavin and vitamin B-6 status. In other studies, a reduced vitamin B-6 status has been found in smokers (Vermaak et al., 1990 ) land a (short-term) reduction of PLP and plasma total vitamin B-6 concentration after a glucose load (Leklem and Hollenbeck, 1990) . Furthermore, the presence of multiple health problems (Manore et al., 1989) and age-related metabolic changes (Guilland et al., 1984; Lee and Leklem, 1985; Kant et al., 1988 ) may lead to higher vitamin B-6 requirements for elderly people.
In the Euronut SENECA study (a Survey in Europe on Nutrition and the Elderly, a Concerted Action) , dietary vitamin B-6 intake and PLP concentration were measured in elderly people living in different towns in Europe according to a standardized study protocol (van't Hof et al., 1991) . The overall prevalence (including those reporting usage of vitamin B-6 containing supplements) of low PLP levels (< 20 nmol/L) was 23%, with considerable variations between the participating towns (Haller et al., 1991) . The purpose of the present study was to examine the combined associations between PLP concentra-B418 VAN DER WIELEN ET AL. tion and dietary vitamin B-6 intake, other dietary factors, indicators of physical health, and lifestyle factors in the Euronut SENECA population.
METHODS
In the Euronut SENECA study, the dietary and health status of elderly people from 19 towns in 12 European countries was measured. In each country, towns were selected with a stable population (no commuter towns) and a socioeconomic structure comparable to the country or the region as a whole. The standardized core protocol called for a random sample, stratified for age and gender van't Hof et al., 1991) . The local research centers could choose either the birth cohorts 1913-1914 (aiming at 60 subjects per town) or 1913-1918 (aiming at 220 subjects per town). Ultimately, 2,586 subjects participated (mean response rate 51%, SD 16). According to a short nonresponders questionnaire, males, nonsmokers, healthier subjects, and better-educated persons were more likely to participate (van't Hof et al., 1991) . Vitamin B-6 status was analyzed in the birth cohort 1913-1914 only, and dietary vitamin B-6 intake was assessed in 12 towns in 9 countries. Only subjects with complete vitamin B-6 data were included in this study (n = 284 males and 264 females).
Fasting blood samples (25 ml) were collected. Whole blood was collected on ethylene-diaminetetra-acetic acid (EDTA) for plasma separation for PLP analysis. Furthermore, Whole blood was collected in dry tubes, with subsequent serum separation for albumin analysis . Serum and plasma samples were stored at -80 °C, sent on dry ice to the coordinating center in Wageningen, The Netherlands, in batch, and stored again at -80 °C. Serum albumin was analyzed by nephelometry at the Nestle" Research Centre in Lausanne, Switzerland. Quality control included the measurement of blind serum duplicates of a commercial control serum (N/T Protein Control Serum; Behrings Werke, Marburg, Germany) with known target value and of a serum pool from healthy donors. Plasma PLP values were determined by radioenzymatic assay using tyrosine decarboxylase apoenzyme (coefficients of variation: within-assay, 1-3%; between assay, 5-8%) (van den Berg et al., 1991) at the TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
Dietary intake data were collected by trained investigators in a personal interview, using a modified dietary history (Cameron and van Staveren, 1988; de Groot and van Staveren, 1988; Nes et al., 1991) . The method comprised a 3-day estimated record and a frequency checklist of foods, based on the meal pattern of the country and with the previous month as a reference period. Usual portion sizes were checked by weighing quantities of food and household measures. Nutrient composition was calculated in each country using local food composition tables .
A general structured interview was used to obtain information on subjective health status, presence of chronic diseases, activities of daily living (ADL), supplement use, level of education, social isolation, and smoking status. ADL was calculated as a sum of scores of level of competence for 16 items, with scores ranging from 1 (no difficulty) to 4 (unable to complete) (Osier et al., 1991) . Subjects were categorized as people having no problems with ADL performance (score 16), people having problems with a few items (score 17-21), and people having more problems (score > 21). By using the cut-off score of 21, the group of subjects with any problems was split up into subgroups of approximately equal size. Body height (to the nearest 0.5 cm) and weight (to the nearest 0.1 kg) were measured with the participants in underclothes only and body mass index (BMI) was calculated as weight divided by height squared (kg/m 2 ). Triceps skinfold thickness was measured to the nearest 0.2 mm with calibrated callipers and mid-upper arm circumference (MUAC) was measured (to the nearest 0.1 cm). Mid-upper arm muscle circumference (MUAMC) was derived from the following equation: MUAMC (cm) = MUAC-0.3142 x triceps skinfold thickness (mm). Details about collected data are reported elsewhere van't Hof et al., 1991) .
Descriptive statistics calculated are frequency distribution or mean values with standard deviation (SD) for males and females separately. After exclusion of vitamin B-6 supplement users, town-and gender-specific mean vitamin B-6 intake and PLP concentration were calculated, along with the proportion of the participants with daily vitamin B-6 intakes below 1.0 mg and/or below .015 mg/g protein and the proportion with a plasma PLP concentration below 20 nmol/L. The cut-off for low vitamin B-6 intake is based on the mean individual minimum requirements as determined by the Dutch Nutrition Council (Netherlands Food and Nutrition Council, 1992) . The cut-off value for low PLP levels corresponds with the 5th percentile of a group of 207 healthy adult (18-65 y) Dutch blood donors (van den Berg et al., 1991) . Differences between males and females and between vitamin B-6 supplement users and nonusers were tested at the 5% significance level with Wilcoxon's ranksum test. Pairwise differences in prevalence of low PLP levels between several subgroups at potential risk of PLP deficiency were tested with Fisher's exact test at the 5% significance level. Associations with potential factors of low PLP levels were studied in linear regression models, after taking the natural logarithm of PLP concentration. All independent variables showing a significant association with PLP after additional inclusion of gender and study town, were included in a multivariate linear regression model to study their effect. All statistical analyses were performed using the SAS package (SAS Institute Inc., Cary, NC).
RESULTS
Mean plasma PLP concentration and distribution of participants selected for this study (Table 1) show that people who took vitamin B-6 supplements on a regular basis had significantly higher PLP levels than those who did not. Since the number of vitamin B-6 supplement users was small and the median PLP level (55 nmol/L) was twice as high as in the nonsupplement users (28 nmol/L), the users were excluded from further analyses. It was concluded from a doseresponse study on the effect of several levels of vitamin B-6 supplementation that PLP levels higher than 150 nmol/L are virtually always a result of supplement use (unpublished data, H.v.d.B.) . Therefore, 14 subjects who claimed not to take vitamin B-6 supplements, but who had PLP levels > 150 nmol/L, were also excluded from further analyses. For comparison, the 90th percentile of the group of 207 healthy adult blood donors (including supplement users) was 75 nmol/L (van den Berg et al., 1991) .
In Table 2 information is presented by gender category on anthropometric and dietary characteristics, as well as on serum albumin. On average, males had a higher body weight and mid-upper arm muscle circumference than females, as well as a higher energy intake. Consequently, males had higher intakes of macronutrients and vitamin B-2 and B-6. The intakes of these vitamins, expressed as mg per g of protein intake, were not different between the two sexes. Serum albumin was higher in males. Table 3 shows the town-and gender-specific vitamin B-6 intakes and PLP levels, as well as prevalence of deficiency.
Daily dietary vitamin B-6 intake ranged between 1.2 and 1.8 mg in males and between 0.8 and 1.5 mg in females. Overall, 27% of the males and 42% of the females had dietary vitamin B-6 intakes below the mean minimum requirements. Median PLP concentration ranged between 21 and 37 nmol/L in males and between 18 and 36 nmol/L in females, with an overall prevalence of biochemical deficiency (< 20 nmol/L) in 22% of both males and females. PLP levels and prevalence < 20 nmol/L are also calculated for several categories of various potential risk factors of low vitamin B-6 status (Table 4) . Median PLP concentration tended to be lower in people who had a poor health status, had problems with performing ADLs, were less educated, and who smoked. Prevalence of low PLP levels was most pronounced in both males and females with many ADL problems (p = .01). After adjustment for gender and study Notes: Data for ADL are based on 16 items. Subjects with reported vitamin B-6 supplement use (n = 54) or with PLP levels > 150 nmol/L (n = 14) were excluded.
•Data missing for one male and one female. site, dietary intake of vitamin B-6, intake of animal protein, alcohol intake, serum albumin, body mass index, severe ADL problems, education level, and smoking status were found to be associated (p < .10) with log-transformed PLP in linear regression models (Table 5) . Gender, living situation, reporting chronic diseases, subjective health feeling, and dietary riboflavin intake were not associated with PLP concentration. To assess the independent effect of each characteristic associated with PLP concentration, the factors were simultaneously included in a multivariate model. Because there were no interactions between gender and reported variables, and there were no indications that the associations with PLP differed for the genders, regression analysis was performed for males and females combined, with gender included in the model. Dietary vitamin B-6 intake remained significantly associated with PLP concentration (p = .01), whereas the intake of animal protein lost its significance when included in the model together with vitamin B-6 intake. Vitamin B-6 intake, expressed in the model per gram of protein intake, was not strongly associated with PLP concentration (p = .07; data not shown). Alcohol intake was positively associated with PLP concentration (p = .01). Serum albumin was most strongly related with PLP concentration (p = .0001). Furthermore, PLP was inversely related with BMI (p = .02). Having problems with performing ADL and level of education were not associated with PLP concentration in the multivariate model. Smoking status was also not significantly associated with PLP concentration; however, after exclusion of serum albumin concentration from the multivariate regression model, current smokers had significantly lower PLP concentrations (p = .02). Exclusion of smoking status from the model did not change the association between serum albumin and PLP concentration.
DISCUSSION
In this standardized multicenter study we examined both dietary vitamin B-6 intake and plasma PLP, as well as several health status and lifestyle parameters, in apparently healthy Europeans aged 74-76 years. Prevalence of inadequate dietary vitamin B-6 intakes and plasma PLP levels was high. Plasma PLP concentration was strongly positively associated with dietary vitamin B-6 intake and with serum albumin. Furthermore, alcohol intake was positively associated and BMI inversely associated with plasma PLP concentration.
The association between dietary vitamin B-6 intake and plasma PLP concentration was relatively strong, despite the use of different country-specific nutrient databases which may have slightly weakened this effect. Since the nutrient databases may have been incomplete and were not up to date with respect to information on the vitamin B-6 content of several foods, the actual association between vitamin B-6 intake and PLP concentration is expected to be somewhat higher than the one found in this study.
The disappearance of the positive association between intake of animal protein and plasma PLP concentration after inclusion of vitamin B-6 intake indicates that animal protein intake reflects the intake of bioavailable vitamin B-6. The lack of association between vegetable protein intake and PLP concentration is in agreement with the findings that vitamin B-6 from vegetable sources may be less bioavailable Notes: Data for ADL are based on 16 items. Subjects with reported vitamin B-6 supplement use (n = 54), with PLP levels > 150 nmol/L (n = 14), or with incomplete data (n = 35) were excluded; n = 511 (261 males, 250 females) in analyses.
•Gender and study site also included in the model. b Gender, study site, and all listed variables simultaneously included in the model.
than vitamin B-6 from animal origin (Leklem et al., 1980; Kretschetal., 1982; Kabiretal., 1983; Fisher et al., 1984) . The association of vitamin B-6 status with (moderate) alcohol consumption has been found in other studies also, in elderly (Herbeth et al., 1989; Lowik et al., 1990b; RibayaMercado, 1992) as well as in younger subjects (Arab et al., 1982) . In alcoholics, however, a negative association has been demonstrated between alcohol consumption and vitamin B-6 status, both measured as PLP or as the PLP-induced erythrocyte aspartate aminotransferase activation coefficient (EAST-AC) (Bonjour, 1980) . In a number of studies the direct actions of alcohol on the biokinetics and metabolism of vitamin B-6 have been examined (Hines, 1969; Lumeng and Li, 1974; Labadarios et al., 1977) . These experimental studies on the interactions between alcohol and vitamin B-6 suggest that PLP degradation is increased and the formation of PLP is reduced by chronic high alcohol intake, but it is not clear whether this occurs only when hepatic pathology is present or which doses of ethanol lead to these changes. Our SENECA data suggest that PLP formation is not impaired and that alcohol contributes positively to the vitamin B-6 status in this population. It may be that alcohol intake reflects vitamin B-6 intake through some alcoholic beverages, since vitamin B-6 contents data partly are missing for these drinks in the Swiss centers and the Dutch center (all using the Dutch food composition table of 1986) (Stichting Nederlands Voedingsstoffenbestand, 1987) and possibly also for other centers.
Unfortunately, the association between fiber intake and PLP concentration could not be studied due to inconsistencies in different types of dietary fiber between the countryspecific food composition tables. Previous studies did not show an adverse effect of dietary fiber on the availability or metabolism of vitamin B-6 (Shultz and Leklem, 1987; Lowik et al., 1990a) . Other studies, however, did find a lower availability of vitamin B-6 from vegetable products (Leklem et al., 1980; Kabir et al., 1983) . Possibly, dietary fiber is a proxy of glycosides, which are known to decrease vitamin B-6 bioavailability when conjugated with this vitamin (Trumbo et al., 1988) .
Albumin is the transport protein of PLP in the bloodstream (Anderson et al., 1974) . Several studies have demonstrated a decline in serum albumin concentration with advancing age (Campion et al., 1988; Klonoff-Cohen et al., 1992; Salive et al., 1992) . Recently it was reported that only 2% of the SENECA population had serum albumin levels below 35 g/L (van Staveren et al., 1995) . The odds ratio of hypoalbuminaemia was 3 to 4 times higher for current and former smokers, respectively, compared with nonsmokers. This finding was in line with other studies (Dales et al., 1974; Stram et al., 1990; Salive et al., 1992) . The present results indicate that the inverse association between smoking and PLP concentration (after exclusion of serum albumin from the model) may be explained by the albumin lowering effect of smoking, even when albumin levels are almost all within the normal range. The PLP binding capacity of this transport protein is not considered to be a limiting factor for the PLP concentrations. However, albumin was positively associated with PLP levels. Whether this is a direct effect of albumin itself (e.g., by protecting PLP against rapid alkaline phosphatase mediated hydrolysis to pyridoxal) or a result of underlying health problems warrants further study. More parameters of vitamin B-6 metabolism should be measured for this purpose.
An inverse association has been found earlier between vitamin B-6 status and body weight but not with BMI in the Boston Nutritional Status Survey (Ribaya-Mercado, 1992) and with ponderal index (as an estimator of body fatness) by Herbeth et al. (1989) . We have no clear explanation for this finding; however, the vitamin B-6 needs might be lower in obese people due to a lower lean body mass, reduced physical activeness, or underlying health problems.
Although the SENECA participants in general were apparently healthy elderly people, 36% reported having one, and another 36% two or more chronic diseases. However, neither this classification, nor classification based on subjective health feeling, was associated with PLP concentration.
An inadequate vitamin B-6 supply may be associated with cardiovascular diseases (Willett, 1985) , some neurological disorders (Coburn, 1985) , and impaired immune function (Ockhuizen et al., 1990) . Based on the dietary recommendations for younger adults, dietary vitamin B-6 intake is inadequate in a large part of these apparently healthy elderly people. As a biomarker of exposure, low PLP levels confirm this finding and indicate that the vitamin B-6 status of these people is inadequate. In order to be able to quantify functional and health consequences of improving the vitamin B-6 status of elderly people, large epidemiological trials are needed. Based on the results of these trials, the vitamin B-6 recommendations for elderly people can be adjusted if necessary.
